Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean acetyl acid and approved type?
Displaying drugs 14901 - 14925 of 15019 in total

N-methyl-1-(2-thiophen-2-ylphenyl)methanamine

Experimental

1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene

Experimental

4-(2-aminoethyl)-2-cyclohexylphenol

Experimental

4,4'-Dihydroxybenzophenone

Experimental

6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL

Experimental

4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE

Experimental

1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE

Experimental

3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA

Experimental

2,6-dibromo-4-phenoxyphenol

Experimental

[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE

Experimental

6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one

Experimental

[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE

Experimental

Diclazuril

Diclazuril is a coccidiostat.
Investigational
Vet approved

Clofoctol

Experimental

Tolpropamine

Experimental

Suloctidil

Experimental

Eprozinol

Experimental

Etybenzatropine

Experimental

Tiocarlide

Experimental

Quifenadine

Experimental

Penfluridol

Experimental

4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE

Experimental

2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE

Experimental

EHT899

EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.
Investigational
Matched Description: … enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and …

RUS 3108

RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and stroke by Dr. Reddy’s Laboratories. The drug’s Phase I clinical trials have been initiated in Europe to assess safety of the drug compound in healthy volunteers.
Investigational
Matched Description: … the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and …
Displaying drugs 14901 - 14925 of 15019 in total